{
    "code": "02018960",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018960",
    "time": "2020-02-25 12:03:23",
    "許可證字號": "衛署藥輸字第018960號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/12\/24",
    "發證日期": "105\/12\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201896002",
    "中文品名": "立服安錠",
    "英文品名": "LEVOHALTE TABLETS",
    "適應症": "躁病、精神病狀態、噁心、嘔吐、攻擊性與破壞性之行障礙。",
    "劑型": "116膜衣錠",
    "包裝": "2-10002錠瓶裝 2-10002錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0605901100  光亨企業有限公司",
        "申請商地址": "新北市汐止區新台五路一段97號26樓之1",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2824001220",
            "成分名稱": "LEVOMEPROMAZINE MALEATE(METHOTRIMEPRAZINE MALEATE)",
            "含量描述": "(33.8MG) 25.0",
            "含量": "",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "06 Levohalte-104-09-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018960&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥輸字第018960號立服安錠-104-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018960&Seq=003&Type=9"
        }
    ]
}